Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTSH-assisted iodine-131 therapy for nontoxic goiter
ChiCTR2500096080Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in goiter comparing rhTSH + iodine-131 with Placebo (saline) + iodine-131 (2 arms). Primary endpoints: Thyroid volume reduction rate at 12 months and Goiter-related quality of life at 12 months. Started Jan 2025; status: recruiting.
02
Drugs
thyrotropin alfa
03
Conditions
goiter
Beyond the preview
Go deeper on ChiCTR2500096080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096080.